Longeveron News

Longeveron (LGVN) Receives a Buy From Maxim Group

TipRanksMar 1 15:25 ET

Buy Rating Affirmed: Longeveron's Intellectual Property and Pipeline Progress Signal Market Growth

TipRanksJan 30 06:15 ET

Buy Rating Affirmed for Longeveron on Promising CLEAR MIND Trial Results and Strong Lomecel-B Potential

TipRanksJan 5 06:31 ET

HC Wainwright Initiates Longeveron With Buy Rating, Price Target Is $6

MT NewswiresDec 4, 2023 08:01 ET

Longeveron Analyst Ratings

BenzingaDec 4, 2023 06:42 ET

Longeveron's Lomecel-B: A Dual-Therapeutic Prospect Transforming Treatment in HLHS and AD With a Strong Buy Rating

TipRanksDec 4, 2023 06:18 ET

Maxim Group Reaffirms Their Buy Rating on Longeveron (LGVN)

TipRanksAug 12, 2023 15:15 ET

EF Hutton Assumes Longeveron at Buy, Announces Price Target of $12.5

BenzingaJun 1, 2023 04:48 ET

Longeveron (LGVN) Gets a Buy From Maxim Group

TipRanksMay 10, 2023 14:35 ET

Longeveron (LGVN) Gets a Buy From EF Hutton

TipRanksMay 9, 2023 16:26 ET

EF Hutton Reiterates Buy on Longeveron, Maintains $12.5 Price Target

BenzingaMay 9, 2023 12:51 ET

Maxim Group Remains a Buy on Longeveron (LGVN)

TipRanksApr 20, 2023 11:38 ET

EF Hutton Reiterates Buy on Longeveron, Maintains $12.5 Price Target

BenzingaMar 27, 2023 09:38 ET

Maxim Group Sticks to Its Buy Rating for Longeveron (LGVN)

TipRanksMar 11, 2023 11:26 ET

Maxim Group Sticks to Its Buy Rating for Longeveron (LGVN)

TipRanksJan 13, 2023 13:00 ET

EF Hutton Adjusts Longeveron Price Target to $12.50 From $20, Maintains Buy Rating

MT NewswiresJan 10, 2023 07:53 ET

EF Hutton Sticks to Their Buy Rating for Longeveron (LGVN)

TipRanksJan 10, 2023 07:30 ET

EF Hutton Maintains Buy on Longeveron, Lowers Price Target to $12.5

Benzinga Real-time NewsJan 10, 2023 07:03 ET

Longeveron Analyst Ratings

Benzinga Analyst RatingsJan 10, 2023 07:03 ET

Maxim Group Sticks to Its Buy Rating for Longeveron (LGVN)

TipRanksAug 16, 2022 12:45 ET